Experiment

Research & Initiatives

Research results are shared freely within Consortium to develop trans-Consortium collaborative projects that make use of the combined expertise and technological capabilities present in all of the Clinical Centers

​The Consortium for the Study of Chronic Pancreatitis, Diabetes and Pancreatic Cancer (CPDPC) was formed to undertake a comprehensive clinical, epidemiological, and biological characterization of patients with Chronic Pancreatitis (including those with Acute Recurrent Pancreatitis, ARP) to gain insight into the pathophysiology of chronic pancreatitis and its sequela: chronic pain, pancreatic insufficiency, T3cDM and the diabetes/pancreatic cancer association.


The multidisciplinary teams will also undertake studies on the development of pancreatic cancer in newly diagnosed diabetic patientse. 

 

On Chronic Pancreatitis (including those with Acute Recurrent pancreatitis, ARP), by identifying and characterizing a large cohort of pediatric and adult patients with CP and ARP to encourage translational research focusing upon elucidating the pathogenesis that will provide the basis for understanding the natural history and developing means of diagnosis, treatment and clinical management of Chronic Pancreatitis and its sequela: chronic pain, pancreatic insufficiency and on pancreatic cancer and pancreatogenic Diabetes Mellitus (T3cDM) and their pathogenic interrelationships, by identifying and following a cohort of newly diagnosed diabetic patients in the setting of CP

Blood Test